Bietti crystalline retinopathy (Q84185): Difference between revisions

From determinar.ia.br - Determine suas informações
‎Created a new Item
 
‎Changed label, description and/or aliases in pt-br, en
description / pt-brdescription / pt-br
 
Retinopatia cristalina de Bietti é uma doença degenerativa tapetorretiniana autossômica recessiva progressiva rara, que ocorre na terceira década de vida, caracterizada por pequenos depósitos cristalinos cintilantes em retina posterior e limbo corneano, além de esclerose dos vasos da coroide, e manifestando-se como cegueira noturna, redução da visão, escotoma paracentral e, nos estágios finais da doença, cegueira legal.
description / endescription / en
 
Bietti crystalline retinopathy is a rare progressive autosomal recessive tapetoretinal degeneration disease, occurring in the third decade of life, characterised by small sparkling crystalline deposits in the posterior retina and corneal limbus in addition to sclerosis of the choroidal vessels and manifesting as nightblindness, decreased vision, paracentral scotoma, and, in the end stages of the disease, legal blindness.

Revision as of 09:32, 15 August 2026

Bietti crystalline retinopathy is a rare progressive autosomal recessive tapetoretinal degeneration disease, occurring in the third decade of life, characterised by small sparkling crystalline deposits in the posterior retina and corneal limbus in addition to sclerosis of the choroidal vessels and manifesting as nightblindness, decreased vision, paracentral scotoma, and, in the end stages of the disease, legal blindness.
Language Label Description Also known as
default for all languages
ID_1922709888
    English
    Bietti crystalline retinopathy
    Bietti crystalline retinopathy is a rare progressive autosomal recessive tapetoretinal degeneration disease, occurring in the third decade of life, characterised by small sparkling crystalline deposits in the posterior retina and corneal limbus in addition to sclerosis of the choroidal vessels and manifesting as nightblindness, decreased vision, paracentral scotoma, and, in the end stages of the disease, legal blindness.

      Statements